57961-90-7 Usage
Description
Centhaquine is a centrally acting hypotensive drug, functioning as an α2 adrenergic agonist, similar to Clonidine (C587120). It is utilized in the medical field to help regulate blood pressure and is known for its effectiveness in treating hypertension.
Uses
Used in Pharmaceutical Industry:
Centhaquine is used as a hypotensive agent for the treatment of high blood pressure. It works by stimulating the α2 adrenergic receptors in the central nervous system, which leads to a reduction in blood pressure and helps maintain cardiovascular health.
Used in Cardiovascular Applications:
In the field of cardiology, Centhaquine is used as a therapeutic agent to manage hypertension. Its α2 adrenergic agonist properties contribute to the regulation of blood pressure, making it a valuable asset in the prevention and treatment of cardiovascular diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 57961-90-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,9,6 and 1 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 57961-90:
(7*5)+(6*7)+(5*9)+(4*6)+(3*1)+(2*9)+(1*0)=167
167 % 10 = 7
So 57961-90-7 is a valid CAS Registry Number.
InChI:InChI=1/C22H25N3/c1-18-5-4-7-21(17-18)25-15-13-24(14-16-25)12-11-20-10-9-19-6-2-3-8-22(19)23-20/h2-10,17H,11-16H2,1H3
57961-90-7Relevant articles and documents
METHODS AND COMPOSITIONS FOR HYPOTENSIVE RESUSCITATION
-
Paragraph 0063, (2014/03/25)
Methods of treating diseases and conditions wherein an improvement in cardiac output, organ perfusion, or tissue oxygenation are disclosed. The methods include treatments of diseases and conditions, such as hypovolemic shock, with an a2 adrener
1-Substituted 4-(β-2-quinolylethyl)piperazines and 1,2,3,4-tetrahydroquinolyl-ethyl analogues thereof
-
, (2008/06/13)
Pharmacologically active 1-substituted 4-(β-2-quinolylethyl)piperazines of the formula SPC1 And their 1,2,3,4-tetrahydroquinolylethyl analogues, wherein R represents a lower alkyl, a phenyl, benzyl or a phenethyl group; and pharmaceutically acceptable aci
